Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal Research

Treating Opioid Addiction With Buprenorphine-Naloxone in Community-Based Primary Care Settings

Ira L. Mintzer, Mark Eisenberg, Maria Terra, Casey MacVane, David U. Himmelstein and Steffie Woolhandler
The Annals of Family Medicine March 2007, 5 (2) 146-150; DOI: https://doi.org/10.1370/afm.665
Ira L. Mintzer
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Eisenberg
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Terra
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Casey MacVane
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David U. Himmelstein
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steffie Woolhandler
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Additional Files
    • View popup
    Table 1.

    Selected Characteristics of Patients Receiving Buprenorphine-Naloxone Treatment at 2 Primary Care Sites (n = 99)

    CharacteristicsValue
    Female, %36
    Mean age, years33
    Non-Hispanic white, %94
    Seropositive for hepatitis C, %25
    Average time in treatment, days105
    Privately insured, %27
    Mean stabilization dose of buprenorphine, mg15
    • View popup
    Table 2.

    Characteristics of Patients Treated With Buprenorphine-Naloxone Who Did and Did Not Maintain Sobriety Over 6 Months

    CharacteristicSober Patients (n = 53)Nonsober Patients (n = 46)PValue
    AA = Alcohol Anonymous; NA = Narcotics Anonymous.
    * Some patients were addicted to >1 drug.
    Attended AA or NA, %5537.09
    Private insurance, %3618.05
    Self-pay, %418.02
    Length of time in treatment, days16962<.01
    Mean buprenorphine dosage, mg/d15.515.3.86
    Female, %3440.54
    Seropositive for hepatitis C, %2624.82
    Addiction to heroin, %*7078.37
    Addiction to methadone, %*60.11
    Addiction to oxycodone/Oxycontin, %*4038.85
    Treated at hospital-based primary care site, %4942.50
    Living in ZIP codes with poverty rates below 10%, %4643.79
    Average age, years3531.05

Additional Files

  • Tables
  • The Article in Brief

    Treating Opioid Addiction With Buprenorphine-Naloxone in Community-Based Primary Care Settings

    Ira L. Mintzer, MD, and colleagues

    Background Buprenorphine is a medication that has been approved for treating patients who are addicted to opioids, a group of drugs that include heroin and some prescription pain relievers. Doctors who receive special certification can provide buprenorphine treatment in their office. This study examines the effectiveness and practicality of buprenorphine treatment in two primary care offices.

    What This Study Found Opioid-addicted patients can be safely treated in primary care offices. In this study, 54% of patients were sober at 6 months, which is similar to success rates in more specialized drug treatment centers.

    Implications

    • Opioid-addicted patients can be safely and effectively treated in primary care offices with limited on-site resources.
    • The authors call for more buprenorphine treatment outside of specialized treatment centers, and they encourage other primary care doctors to consider providing such treatment.
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 5 (2)
The Annals of Family Medicine: 5 (2)
Vol. 5, Issue 2
1 Mar 2007
  • Table of Contents
  • Index by author
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Treating Opioid Addiction With Buprenorphine-Naloxone in Community-Based Primary Care Settings
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Treating Opioid Addiction With Buprenorphine-Naloxone in Community-Based Primary Care Settings
Ira L. Mintzer, Mark Eisenberg, Maria Terra, Casey MacVane, David U. Himmelstein, Steffie Woolhandler
The Annals of Family Medicine Mar 2007, 5 (2) 146-150; DOI: 10.1370/afm.665

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Treating Opioid Addiction With Buprenorphine-Naloxone in Community-Based Primary Care Settings
Ira L. Mintzer, Mark Eisenberg, Maria Terra, Casey MacVane, David U. Himmelstein, Steffie Woolhandler
The Annals of Family Medicine Mar 2007, 5 (2) 146-150; DOI: 10.1370/afm.665
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Integrating Buprenorphine Treatment for Opioid Use with Primary Care is Associated with Greater Retention in Treatment
  • Treatment of opioid use disorder in primary care
  • Predictors of Family Medicine Patient Retention in Opioid Medication-Assisted Treatment
  • Financing Buprenorphine Treatment in Primary Care: A Microsimulation Model
  • Now is the Time to Address Substance Use Disorders in Primary Care
  • Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence: Retrospective cohort study of 30 patients
  • Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: Evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program
  • Buprenorphine: New treatment of opioid addiction in primary care
  • On TRACK: Primary Care Opportunities for Filling Unmet Need
  • In This Issue: Real Change Is Real Hard in the Real World
  • Google Scholar

More in this TOC Section

  • Family-Based Interventions to Promote Weight Management in Adults: Results From a Cluster Randomized Controlled Trial in India
  • Teamwork Among Primary Care Staff to Achieve Regular Follow-Up of Chronic Patients
  • Shared Decision Making Among Racially and/or Ethnically Diverse Populations in Primary Care: A Scoping Review of Barriers and Facilitators
Show more Original Research

Similar Articles

Subjects

  • Domains of illness & health:
    • Chronic illness
  • Methods:
    • Quantitative methods
  • Other research types:
    • Health services
    • Professional practice
  • Core values of primary care:
    • Access

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine